Table 2 Published case reports on rPPK management and outcomes
Medication used to lower k | CRRT | WBC after chemotherapy | K level after normalization of WBC (mmol/L) | Outcome | |
|---|---|---|---|---|---|
1 | NA | NA | NA | NA | NA |
2 | Calcium chloride, albuterol, dextrose-insulin, furosemide, and sodium polystyrene sulfonate | Planned but not done | NA | NA | no dialysis was performed, and potassium supplements were administered |
3 | NA | NA | 3.7 | 4 | NA |
4 | None | None | NA | NA | NA |
5 | None | None | 150 | 4 | |
6 | Intravenous calcium gluconate, intravenous insulin, and oral sodium polystyrene sulfonate | Partial hemodialysis | NA | NA | Hemodialysis stoped and patient treatend as rPHK |
7 | None | None | NA | 4.3 | Received chemo without complication and discharge home in good condition |
8 | Insulin plus glucose and sodium polystyrene | NA | NA | 3.1 (after chemotherapy) | Received chemotherapy, no TLS or complication |
9 | Insulin and oral sodium Polystyrene sulfonate | Hemodialysis Day 3–6 | 100 | 3–3.2 | Chemotherapy initiated His serum potassium level was maintained within the normal range during the rest of his hospital stay, whereas WBC counts continued to decrease with the progression of chemotherapy |
10 | NA | NA | 364 | WBC Never normalized | entered palliative care following multifocal intracerebral hemorrhage and died approximately two weeks after presentation |
11 | NA | NA | NA | NA | Paroxysmal atrial fibrillation (Ibrutinib was suspended and cardioversion with amiodarone was performed with success) Oral Cyclophosphamide with no SE |
12 | 17 cases received either SPS, insulin, furosemide, NaHco3, | Hemodialysis in 3 cases (who are CKD or ESRD) | NA | NA | 6(15%) died during hospitalization 4 received Potassium-lowering therapy and 4 had an HM |
13 | NA | NA | NA | NA | NA |
14 | Calcium gluconate, insulin, and dextrose cocktail | None | Discharged to home and advised regular follow-ups with her oncologist |